Philip Thompson
Hematology & Oncology · Houston, TXNPI 1184051203
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,420 of the $17,246 with a category attached, or 89.4%. 10 manufacturers reported payments, led by Eli Lilly at 26.9% of the total. Reporting peaked in 2022 at $10,078 and has fallen 92.1% since, to $800 in 2023.
Across 27 payments — averaging $638.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$5K
- Genentech USA, Inc.$4K
- AbbVie$4K
- Adaptive Biotechnologies Corporation$3K
- Astrazeneca UK Limited$685
- Genentech, Inc.$535
- plus $903 from 4 others
Across 89 payments — averaging $153,047 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$10.9M
- Pharmacyclics LLC, An Abbvie Company$1.5M
- Eli Lilly$634K
- Acerta Pharma LLC$247K
- Merck$214K
- Adaptive Biotechnologies Corporation$64K
- plus $55K from 1 others
What the payments were for
- Consulting fees$15,42089%
- Food & beverage$1,82611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 4 | $4,643 |
| Genentech USA, Inc. | 5 | $3,829 |
| AbbVie | 2 | $3,550 |
| Adaptive Biotechnologies Corporation | 6 | $3,101 |
| Astrazeneca UK Limited | 1 | $685 |
| Genentech, Inc. | 4 | $535 |
| Beigene USA, Inc. | 1 | $525 |
| AstraZeneca | 2 | $252 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $74 |
| Bristol Myers Squibb | 1 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,246 in reported general payments places this provider in the 75th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in Houston
- Devesh PandyaHouston$1.8M
- Elias JabbourHouston$1.3M
- Naval DaverHouston$853K
- Jorge Cortes-FrancoHouston$627K
- Courtney DinardoHouston$478K
- Prithviraj BoseHouston$463K
- Milind JavleHouston$326K
- Loretta NastoupilHouston$309K
- Boyu HuHouston$281K
- Luis CamachoHouston$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.